Skip Navigation

Cardiovascular Research 2002 54(1):36-41; doi:10.1016/S0008-6363(01)00537-5
© 2002 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Rekhter, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rekhter, M. D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2002, European Society of Cardiology

How to evaluate plaque vulnerability in animal models of atherosclerosis?

Mark D. Rekhter*

Department of Cardiovascular Pharmacology, Pfizer Global Research and Development, Ann Arbor Laboratories, 2800 Plymouth Road, Ann Arbor, MI 48105, USA

* Tel.: +1-734-662-2970; fax: +1-734-662-1480 mark.rekhter{at}pfizer.com

Prevention of heart attack and stroke depends on detection of vulnerable plaques and development of plaque-stabilizing therapies. In turn, progress in diagnostics and treatment is contingent on our understanding of molecular mechanisms of plaque vulnerability. Animal models are essential for testing mechanistic hypotheses in a controlled manner. Currently, there is no single, golden standard animal model of a vulnerable plaque. However, the whole range of experimental approaches is readily available. It includes traditional models of atherosclerosis combined with new ‘vulnerability endpoints’, as well as several models featuring spontaneous or induced plaque rupture/thrombosis. This review summarizes current literature on the animal models of vulnerable atherosclerotic plaques.

KEYWORDS Atherosclerosis; Thrombosis/embolism


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
P. C. Dimayuga, X. Zhao, J. Yano, and K.-Y. Chyu
Changes in immune responses to oxidized LDL epitopes during aging in hypercholesterolemic apoE(-/-) mice
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2006; 291(6): R1644 - R1650.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
C. Cheng, D. Tempel, R. van Haperen, A. van der Baan, F. Grosveld, M. J.A.P. Daemen, R. Krams, and R. de Crom
Atherosclerotic Lesion Size and Vulnerability Are Determined by Patterns of Fluid Shear Stress
Circulation, June 13, 2006; 113(23): 2744 - 2753.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
T. Sasaki, M. Kuzuya, K. Nakamura, X. W. Cheng, T. Shibata, K. Sato, and A. Iguchi
A Simple Method of Plaque Rupture Induction in Apolipoprotein E-Deficient Mice
Arterioscler Thromb Vasc Biol, June 1, 2006; 26(6): 1304 - 1309.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. Tjwa, P. Carmeliet, and L. Moons
Novel Transgenic Rabbit Model Sheds Light on the Puzzling Role of Matrix Metalloproteinase-12 in Atherosclerosis
Circulation, April 25, 2006; 113(16): 1929 - 1932.
[Full Text] [PDF]

Home page
 Physiol. Rev.Home page
A. C. Newby
Dual Role of Matrix Metalloproteinases (Matrixins) in Intimal Thickening and Atherosclerotic Plaque Rupture
Physiol Rev, January 1, 2005; 85(1): 1 - 31.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
K.J. Molloy, M.M. Thompson, J.L. Jones, E.C. Schwalbe, P.R.F. Bell, A.R. Naylor, and I.M. Loftus
Unstable Carotid Plaques Exhibit Raised Matrix Metalloproteinase-8 Activity
Circulation, July 20, 2004; 110(3): 337 - 343.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
P. Cullen, R. Baetta, S. Bellosta, F. Bernini, G. Chinetti, A. Cignarella, A. von Eckardstein, A. Exley, M. Goddard, M. Hofker, et al.
Rupture of the Atherosclerotic Plaque: Does a Good Animal Model Exist?
Arterioscler Thromb Vasc Biol, April 1, 2003; 23(4): 535 - 542.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
W. Palinski and C. Napoli
Unraveling Pleiotropic Effects of Statins on Plaque Rupture
Arterioscler Thromb Vasc Biol, November 1, 2002; 22(11): 1745 - 1750.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.